Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04532814 · ClinicalTrials.gov registry record · NA

Exercise-stimulated Muscle Glucose Uptake in Upper Body Obesity

A NA study of Upper Body Obesity, sponsored by Mayo Clinic.

Active
Registry status
NA
Development phase
48
Enrollment target
1
Study location

NCT04532814: Active NA study of Upper Body Obesity, sponsored by Mayo Clinic.

NCT04532814 is a NA study of Upper Body Obesity that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 48 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04532814, a NA study of Upper Body Obesity, is active but no longer recruiting, sponsored by Mayo Clinic.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
48 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to provide the first integrated examination of the interaction between muscle insulin action and exercise-stimulated muscle glucose uptake in obesity from the whole body to the cellular/molecular level.

Primary Outcome

Is exercise induced skeletal muscle glucose uptake different in obese compared to lean adults

Conditions Studied

Interventions

  • OTHER Exercise

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2020-11-06
Est. Completion 2026-07-31
Phase NA
Mayo Clinic

2,844 total trials

What the registry record for NCT04532814 still lists

NCT04532814 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Upper Body Obesity appearing as the primary indexed condition, and to 1 intervention - of which Exercise is the first listed.

NCT04532814 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT04532814 about?

NCT04532814 is a clinical study titled "Exercise-stimulated Muscle Glucose Uptake in Upper Body Obesity". The purpose of this study is to provide the first integrated examination of the interaction between muscle insulin action and exercise-stimulated muscle glucose uptake in obesity from the whole body to the cellular/molecular level.

What is the current status of trial NCT04532814?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2020-11-06. Estimated completion is 2026-07-31.

What conditions does trial NCT04532814 study?

This clinical trial studies the following conditions: Upper Body Obesity.

What interventions are being tested in trial NCT04532814?

The interventions under investigation include: Exercise (OTHER).

Who is sponsoring clinical trial NCT04532814?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04532814 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT04532814's enrollment target sits among peer trials

48 1381st of 2000 higher than 601 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01765777 · 48 participants · NA

    Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain

  • NCT03073343 · 48 participants · NA

    A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

  • NCT03431064 · 48 participants

    Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients

  • NCT03514602 · 48 participants · NA

    Maternal Smoking Cessation and Pediatric Obesity Prevention

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04532814, the US trial registry maintained by the National Library of Medicine. NCT04532814 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.